脑电活动生物标志物用于急诊科创伤性颅脑损伤分诊:多中心前瞻性观察验证试验
该多中心前瞻性观察验证试验在美国11家急诊科纳入720例18–85岁、头部闭合伤后72小时内就诊、GCS 12–15的患者(97%为GCS 15),采集额区与额颞区5–10分钟脑电图,用事先在独立人群建立的分类算法前瞻性判断CT阳性可能性。二元分类检测任何CT可见颅内损伤的敏感性92.3%(95%CI 87.8%–95.5%)、特异性51.6%(95%CI 48.1%–55.1%)、阴性预测值96.0%(95%CI 93.2%–97.9%);三元分类对创伤性血肿(≥1 mL血液)敏感性98.6%(95%CI 92.6%–100.0%)、阴性预测值98.2%(95%CI 95.5%–99.5%)。作者认为该脑电分类算法获取结果快、在急诊环境易用,可能影响头部外伤患者的分诊与临床管理。
要点
- 在GCS 12–15的急诊头部外伤患者中,脑电二元分类预测CT阳性的敏感性92.3%(95%CI 87.8%–95.5%)、特异性51.6%(95%CI 48.1%–55.1%)。
- 二元分类的阴性预测值为96.0%(95%CI 93.2%–97.9%),可用于辅助判断CT阴性可能性。
- 三元分类对创伤性血肿(≥1 mL血液)敏感性98.6%(95%CI 92.6%–100.0%)、阴性预测值98.2%(95%CI 95.5%–99.5%)。
- 研究人群97%为GCS 15,GCS第一和第三四分位数均为15(四分位距=0),结果主要适用于高功能状态患者。
- 脑电采集仅需5–10分钟,在急诊环境易用,作者认为该算法有潜力影响分诊与临床管理。
适用人群与场景
- 因闭合性头部外伤在伤后72小时内到急诊科评估的成人患者,年龄18–85岁,GCS 12–15。
- 研究人群97%为GCS 15,GCS第一和第三四分位数均为15(四分位距=0)。
处置流程与药物剂量
- 进行标准临床评估,并从额区与额颞区头皮位置采集5–10分钟脑电图。
- 使用事先在独立人群建立、前瞻性应用于本验证人群的脑电分类算法,判定每例患者CT阳性的可能性。
研究设计与关键结果
- 研究为观察性前瞻性验证试验,在美国11家急诊科纳入720例18–85岁、GCS 12–15的头部闭合伤患者。
- 二元分类(可能CT阳性或可能CT阴性)检测任何CT可见颅内损伤(CT阳性)的敏感性92.3%(95%CI 87.8%–95.5%)、特异性51.6%(95%CI 48.1%–55.1%)、阴性预测值96.0%(95%CI 93.2%–97.9%)。
- 三元分类(可能CT阳性、不确定、可能CT阴性)对创伤性血肿(≥1 mL血液)的敏感性98.6%(95%CI 92.6%–100.0%)、阴性预测值98.2%(95%CI 95.5%–99.5%)。
- 作者报告特异性显著高于标准CT决策规则。
证据类型、等级与局限
- 证据类型:多中心前瞻性观察验证试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对GCS 12–15的急诊头部外伤患者,脑电分类算法可在5–10分钟内给出CT阳性可能性的判断,高阴性预测值可辅助分诊决策。
- 作者认为该算法获取结果快、在急诊环境易用,有潜力影响头部外伤患者的分诊与临床管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: A brain electrical activity biomarker for identifying traumatic brain injury (TBI) in emergency department (ED) patients presenting with high Glasgow Coma Scale (GCS) after sustaining a head injury has shown promise for objective, rapid triage. The main objective of this study was to prospectively evaluate the efficacy of an automated classification algorithm to determine the likelihood of being computed tomography (CT) positive, in high-functioning TBI patients in the acute state.
METHODS: Adult patients admitted to the ED for evaluation within 72 hours of sustaining a closed head injury with GCS 12 to 15 were candidates for study. A total of 720 patients (18-85 years) meeting inclusion/exclusion criteria were enrolled in this observational, prospective validation trial, at 11 U.S. EDs. GCS was 15 in 97%, with the first and third quartiles being 15 (interquartile range = 0) in the study population at the time of the evaluation. Standard clinical evaluations were conducted and 5 to 10 minutes of electroencephalogram (EEG) was acquired from frontal and frontal-temporal scalp locations. Using an a priori derived EEG-based classification algorithm developed on an independent population and applied to this validation population prospectively, the likelihood of each subject being CT+ was determined, and performance metrics were computed relative to adjudicated CT findings.
RESULTS: Sensitivity of the binary classifier (likely CT+ or CT-) was 92.3% (95% confidence interval [CI] = 87.8%-95.5%) for detection of any intracranial injury visible on CT (CT+), with specificity of 51.6% (95% CI = 48.1%-55.1%) and negative predictive value (NPV) of 96.0% (95% CI = 93.2%-97.9%). Using ternary classification (likely CT+, equivocal, likely CT-) demonstrated enhanced sensitivity to traumatic hematomas (≥1 mL of blood), 98.6% (95% CI = 92.6%-100.0%), and NPV of 98.2% (95% CI = 95.5%-99.5%).
CONCLUSION: Using an EEG-based biomarker high accuracy of predicting the likelihood of being CT+ was obtained, with high NPV and sensitivity to any traumatic bleeding and to hematomas. Specificity was significantly higher than standard CT decision rules. The short time to acquire results and the ease of use in the ED environment suggests that EEG-based classifier algorithms have potential to impact triage and clinical management of head-injured patients.
参考来源
- Hanley D, Prichep LS, Bazarian J, et al. Emergency Department Triage of Traumatic Head Injury Using a Brain Electrical Activity Biomarker: A Multisite Prospective Observational Validation Trial. Acad Emerg Med. 2017. PMID: 28177169. doi:10.1111/acem.13175
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。